<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04633577</url>
  </required_header>
  <id_info>
    <org_study_id>2020-1000</org_study_id>
    <nct_id>NCT04633577</nct_id>
  </id_info>
  <brief_title>Effect of Intravenous Lidocaine on Propofol Requirements</brief_title>
  <official_title>The Effect of Intravenous Lidocaine on Propofol Requirements in Patients Undergoing Hysteroscopy and Diagnostic Curettage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General Hospital of Ningxia Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>General Hospital of Ningxia Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lidocaine, an amide local anesthetic, has advantages of low price and easily obtaining.&#xD;
      Intravenous lidocaine (IVL)initially has been used in the treatment of arrhythmia. It was&#xD;
      demonstrated that IVL had analgesic effect, especially in colorectal surgery, but remained&#xD;
      controversy in other types of surgeries. Other beneficial effects, such as prevention of&#xD;
      hyperalgesia and propofol-induced injection pain, reduction of incidence of postoperative&#xD;
      ileus and nausea and vomiting and anti-inflammatory also were proposed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The most frequent drugs for procedural sedation and analgesia are propofol, benzodiazepines&#xD;
      and opioids. However, these drugs may cause respiratory depression and circulatory&#xD;
      instability. Combination will increase the risk of hypoxia and apnea.&#xD;
&#xD;
      In China, most anesthesia for hysteroscopy and gastroenteroscopy is procedural sedation and&#xD;
      analgesia(PAS) provided by anesthetists. Foester et,al. have been tested that IVL could&#xD;
      significantly reduce propofol requirements „ÄÅpostoperative pain and fatigue scores in&#xD;
      colonoscopy. Chen,et,al. find the same effect of IVL in elderly. However, there is no&#xD;
      research reporting IVL used in hysteroscopy and diagnostic curettage. So, our main objective&#xD;
      is to evaluate the effect of intravenous lidocaine on propofol requirements in patients&#xD;
      undergoing hysteroscopy and diagnostic curettage.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">March 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Propofol Requirements</measure>
    <time_frame>from loss of conciousness to end of procedure</time_frame>
    <description>propofol requirements at loss of conciousness and supplemental requirements during procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>immediately, 15 min, 30 min in PACU</time_frame>
    <description>Assessed pain score using 0-10 cm VAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue score</measure>
    <time_frame>immediately, 15 min, 30 min in PACU</time_frame>
    <description>Assessed fatigue score using 0-10 cm VAS</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>Group Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 eligible patients are received 1.5mg/kg 1%lidocaine intravenously over 30-60s. Then, 4mg/kg/h lidocaine infused intravenously until end of procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2020 eligible patients are received equal 0.9% normal saline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Iv</intervention_name>
    <description>A bolos of 1.5mg/kg lidocaine will be administered before induction. Then, infusion of 4mg/kg/h lidocaine will maintain during procedure.</description>
    <arm_group_label>Group Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% normal saline</intervention_name>
    <description>0.9% normal saline</description>
    <arm_group_label>Group Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who underwent hysteroscopy and diagnostic curettage, American Society of&#xD;
             Anesthesiologist' physical status 1-2, BMI 18.5-24.9 kg/m2,&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with known allergy to lidocaine or other local anesthetics, taken sedatives&#xD;
             and analgesics within 1 week before surgery, mental and neurological diseases, hearing&#xD;
             impairment, unwilling to sign informed consent or participate in the study, serious&#xD;
             arrhythmia and organic heart disease.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Only female could undergo hysteroscopy and diagnostic curettage</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>General Hospital of Ningxia Medical University</name>
      <address>
        <city>Yinchuan</city>
        <state>Ningxia</state>
        <zip>750004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Forster C, Vanhaudenhuyse A, Gast P, Louis E, Hick G, Brichant JF, Joris J. Intravenous infusion of lidocaine significantly reduces propofol dose for colonoscopy: a randomised placebo-controlled study. Br J Anaesth. 2018 Nov;121(5):1059-1064. doi: 10.1016/j.bja.2018.06.019. Epub 2018 Aug 1.</citation>
    <PMID>30336850</PMID>
  </reference>
  <reference>
    <citation>Chen M, Lu Y, Liu H, Fu Q, Li J, Wu J, Shangguan W. The propofol-sparing effect of intravenous lidocaine in elderly patients undergoing colonoscopy: a randomized, double-blinded, controlled study. BMC Anesthesiol. 2020 May 30;20(1):132. doi: 10.1186/s12871-020-01049-z.</citation>
    <PMID>32473649</PMID>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 12, 2020</study_first_submitted>
  <study_first_submitted_qc>November 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2020</study_first_posted>
  <last_update_submitted>November 17, 2020</last_update_submitted>
  <last_update_submitted_qc>November 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intravenous lidocaine</keyword>
  <keyword>propofol</keyword>
  <keyword>pain score</keyword>
  <keyword>fatigue score</keyword>
  <keyword>dose</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

